Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

David T. Liss*, Manisha Cherupally, Matthew J. O’Brien, Raymond H. Kang, Cassandra Aikman, Amisha Wallia, Andrew J. Cooper, Eleena Koep, Emily D. Parker, Ronald T. Ackermann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science